Through its CCR2 receptor affinity [70–72], it activates downstream signaling pathways, such as p42/44 MAPK, phospholipase C-γ, and protein kinase C. Elevated levels of CCL2 protein and mRNA expression are implicated in cancer, showing a high tumor grade and poor prognosis [73]. The gene discussed is CCL2; the disease is neoplasm.